Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 35, Issue 4, 2016, Pages 397-406

  Levine, Deborah J ^a   Glanville, Allan R ^b   Aboyoun, Christina ^b   Belperio, John ^c   Benden, Christian ^d   Berry, Gerald J ^e   Hachem, Ramsey ^f   Hayes, Don ^g   Neil, Desley ^h   Reinsmoen, Nancy L ⁱ   Snyder, Laurie D ^j   Sweet, Stuart ^f   Tyan, Dolly ^e   Verleden, Geert ^k   Westall, Glen ^l   Yusen, Roger D ^f   Zamora, Martin ^m   Zeevi, Adriana ⁿ  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j DUKE UNIVERSITY   (United States)

^k UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^l ALFRED HOSPITAL   (Australia)

^m UNIVERSITY OF COLORADO   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

allograft dysfunction; HLA antibodies; lung transplantation; rejection

Indexed keywords

HLA ANTIGEN; ALLOANTIBODY;

ANTIBODY MEDIATED REJECTION; ARTICLE; CONSENSUS; DISEASE SEVERITY; DONOR; HISTOPATHOLOGY; HUMAN; IMMUNOLOGY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MONITORING; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SOCIETY; ALLOTRANSPLANTATION; GRAFT REJECTION; HEART TRANSPLANTATION; INTERNATIONAL COOPERATION; MEDICAL SOCIETY;

CONSENSUS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INTERNATIONAL COOPERATION; ISOANTIBODIES; LUNG TRANSPLANTATION; SOCIETIES, MEDICAL; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84962162246     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.01.1223     Document Type: Article

References (78)

1. R.R. Hachem, R.D. Yusen, B.F. Meyers, and et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation J Heart Lung Transplant 29 2010 973 980
2. L.J. Lobo, R.M. Aris, J. Schmitz, and et al. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation J Heart Lung Transplant 32 2013 70 77
3. L.G. Hidalgo, P.M. Campbell, B. Sis, and et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure Am J Transplant 9 2009 2532 2541
4. C. Lefaucheur, A. Loupy, G.S. Hill, and et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation J Am Soc Nephrol 21 2010 1398 1406
5. N. Singh, A. Djamali, D. Lorentzen, and et al. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes Transplantation 90 2010 1079 1084
6. C. Wiebe, I.W. Gibson, T.D. Blydt-Hansen, and et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant Am J Transplant 12 2012 1157 1167
7. M.R. Morrell, J.M. Pilewski, C.J. Gries, and et al. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation J Heart Lung Transplant 33 2014 1288 1294
8. S. Safavi, D.R. Robinson, S. Soresi, and et al. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation J Heart Lung Transplant 33 2014 1273 1281
9. W.M. Baldwin 3rd, E.K. Kasper, A.A. Zachary, and et al. Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection Am J Transplant 4 2004 311 318
10. K.C. Meyer, G. Raghu, G.M. Verleden, and et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome Eur Respir J 44 2014 1479 1503
11. P.F. Halloran, J.P. Reeve, A.B. Pereira, and et al. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies Kidney Int 85 2014 258 264
12. A. Loupy, G.S. Hill, and S.C. Jordan The impact of donor-specific anti-HLA antibodies on late kidney allograft failure Nat Rev Nephrol 8 2012 348 357
13. B.D. Tait, C. Susal, H.M. Gebel, and et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation Transplantation 95 2013 19 47
14. M. Haas, B. Sis, L.C. Racusen, and et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions Am J Transplant 14 2014 272 283
15. A. Zeevi, J. Lunz, B. Feingold, and et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients J Heart Lung Transplant 32 2013 98 105
16. P.S. Russell, C.M. Chase, H.J. Winn, and et al. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity J Immunol 152 1994 5135 5141
17. M. Schnaidt, C. Weinstock, M. Jurisic, and et al. HLA antibody specification using single-antigen beads - a technical solution for the prozone effect Transplantation 92 2011 510 515
18. D.B. Tyan New approaches for detecting complement-fixing antibodies Curr Opin Organ Transplant 17 2012 409 415
19. A. Loupy, C. Lefaucheur, D. Vernerey, and et al. Complement-binding anti-HLA antibodies and kidney-allograft survival N Engl J Med 369 2013 1215 1226
20. S.A. Yousem, and A. Zeevi The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies Am J Surg Pathol 36 2012 987 992
21. K. Murata, and W.M. Baldwin III Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection Transplant Rev (Orlando) 23 2009 139 150
22. H.H. Kuo, C.N. Morrell, and W.M. Baldwin III Alloantibody induced platelet responses in transplants: potent mediators in small packages Hum Immunol 73 2012 1233 1238
23. B.A. Wasowska Mechanisms involved in antibody- and complement-mediated allograft rejection Immunol Res 47 2010 25 44
24. T. Akiyoshi, T. Hirohashi, A. Alessandrini, and et al. Role of complement and NK cells in antibody mediated rejection Hum Immunol 73 2012 1226 1232
25. D. Dragun, R. Catar, A. Kusch, and et al. Non-HLA-antibodies targeting angiotensin type 1 receptor and antibody mediated rejection Hum Immunol 73 2012 1282 1286
26. F. Li, X. Zhang, Y.P. Jin, and et al. Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner Hum Immunol 72 2011 1150 1159
27. B. Sis Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection Hum Immunol 73 2012 1218 1225
28. M. Trayssac, A. Negre-Salvayre, and M. Thomsen Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies Hum Immunol 73 2012 1253 1260
29. X. Zhang, N.M. Valenzuela, and E.F. Reed HLA class I antibody-mediated endothelial and smooth muscle cell activation. Curr Opin Organ Transplant 17 2012 446 451
30. E.W. Tsai, and E.F. Reed MHC class I signaling: new functional perspectives for an old molecule Tissue Antigens 83 2014 375 381
31. N.M. Valenzuela, J.T. McNamara, and E.F. Reed Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms Curr Opin Organ Transplant 19 2014 33 40
32. N.J. Sarma, V. Tiriveedhi, N. Angaswamy, and et al. Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications Hum Immunol 73 2012 1275 1281
33. V. Tiriveedhi, M. Takenaka, N.J. Sarma, and et al. Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens J Heart Lung Transplant 32 2013 714 722
34. M. Takenaka, V. Tiriveedhi, V. Subramanian, and et al. Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease PLoS One 7 2012 e42370
35. N. Fukami, S. Ramachandran, D. Saini, and et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection J Immunol 182 2009 309 318
36. B. Charreau Signaling of endothelial cytoprotection in transplantation Hum Immunol 73 2012 1245 1252
37. G. Berry, M. Burke, C. Andersen, and et al. Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT J Heart Lung Transplant 32 2013 14 21
38. A.C. Roden, J.J. Maleszewski, E.S. Yi, and et al. Reproducibility of complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies J Heart Lung Transplant 33 2014 1223 1232
39. L.C. Racusen, P.F. Halloran, and K. Solez Banff 2003 meeting report: new diagnostic insights and standards Am J Transplant 4 2004 1562 1566
40. G.M. Verleden, G. Raghu, K.C. Meyer, and et al. A new classification system for chronic lung allograft dysfunction J Heart Lung Transplant 33 2014 127 133
41. J. Kobashigawa, M.G. Crespo-Leiro, S.M. Ensminger, and et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 2011 252 269
42. S.K. Takemoto, A. Zeevi, S. Feng, and et al. National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1041
43. T.L. Astor, M. Galantowicz, A. Phillips, and et al. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation Am J Transplant 9 2009 409 412
44. A.L. Girnita, K.R. McCurry, S.A. Yousem, and et al. Antibody-mediated rejection in lung transplantation: case reports Clin Transpl 2006 508 510
45. D. Hayes Jr, N. DiPaola, P.B. Baker, and et al. Antibody-mediated rejection in a lung transplant recipient after acute stroke Transpl Immunol 27 2012 171 174
46. R. Jackups Jr, C. Canter, S.C. Sweet, and et al. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection J Clin Apher 28 2013 301 308
47. Todd LA, Hayes D Jr. Diagnosis and management of antibody-mediated rejection following pediatric lung transplantation. In: Goldfarb S, Benden C, Sweet S, Kirklin JK, editors. Elsevier Inc., New York ISHLT Monograph on Pediatric Lung Transplantation; 2013:137-49.
48. S.A. Yousem, G.J. Berry, P.T. Cagle, and et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection J Heart Lung Transplant 15 1996 1 15
49. S. Stewart, M.C. Fishbein, G.I. Snell, and et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection J Heart Lung Transplant 26 2007 1229 1242
50. D. Hayes Jr, A. Naguib, S. Kirkby, and et al. Comprehensive evaluation of lung allograft function in infants after lung and heart-lung transplantation J Heart Lung Transplant 33 2014 507 513
51. T.L. Astor, D. Weill, C. Cool, and et al. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function J Heart Lung Transplant 24 2005 2091 2097
52. C. Baum, H. Reichenspurner, and T. Deuse Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation J Heart Lung Transplant 32 2013 1270 1271
53. C.A. Beaty, A. Yang, T.J. George, and et al. Unilateral humoral rejection after reoperative single-lung transplant Ann Thorac Surg 95 2013 e79 e81
54. F. Chen, N. Chibana, A. Kanematsu, and et al. Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case Surg Today 42 2012 808 811
55. A.H. Daoud, and A.D. Betensley Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series Transpl Immunol 28 2013 1 5
56. M.R. Morrell, G.A. Patterson, E.P. Trulock, and et al. Acute antibody-mediated rejection after lung transplantation J Heart Lung Transplant 28 2009 96 100
57. J. Neumann, H. Tarrasconi, A. Bortolotto, and et al. Acute humoral rejection in a lung recipient: reversion with bortezomib Transplantation 89 2010 125 126
58. S. Rummler, K. Maier, and D. Barz Therapeutic apheresis in transplantation medicine, experience with cardiac and lung transplantation in Jena Atheroscler Suppl 14 2013 33 38
59. L.J. Stuckey, M. Kamoun, and K.M. Chan Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction Ann Pharmacother 46 2012 e2
60. C.A. Witt, J.P. Gaut, R.D. Yusen, and et al. Acute antibody-mediated rejection after lung transplantation J Heart Lung Transplant 32 2013 1034 1040
61. D.B. Badesch, M. Zamora, D. Fullerton, and et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection J Heart Lung Transplant 17 1998 415 422
62. D. Hadjiliadis, C. Chaparro, N.L. Reinsmoen, and et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study J Heart Lung Transplant 24 suppl 2005 S249 S254
63. A.L. Girnita, R. Duquesnoy, S.A. Yousem, and et al. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction Am J Transplant 5 2005 131 138
64. A.L. Girnita, K.R. McCurry, A.T. Iacono, and et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection J Heart Lung Transplant 23 2004 1135 1141
65. S. Sundaresan, T. Mohanakumar, M.A. Smith, and et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome Transplantation 65 1998 648 653
66. A. Jaramillo, M.A. Smith, D. Phelan, and et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation Transplantation 67 1999 1155 1161
67. R.R. Hachem, V. Tiriveedhi, G.A. Patterson, and et al. Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation Am J Transplant 12 2012 2164 2171
68. C.C. Magee, J. Felgueiras, K. Tinckam, and et al. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one centers experience Transplantation 86 2008 96 103
69. R.A. Montgomery, B.E. Lonze, K.E. King, and et al. Desensitization in HLA-incompatible kidney recipients and survival N Engl J Med 365 2011 318 326
70. A.A. Vo, M. Lukovsky, M. Toyoda, and et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation N Engl J Med 359 2008 242 251
71. A.A. Vo, A. Peng, M. Toyoda, and et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation Transplantation 89 2010 1095 1102
72. A.A. Vo, J. Petrozzino, K. Yeung, and et al. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab Transplantation 95 2013 852 858
73. O. Brugiere, C. Suberbielle, G. Thabut, and et al. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay Transplantation 95 2013 761 765
74. M. Kim, K.R. Townsend, I.G. Wood, and et al. Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates Am J Respir Crit Care Med 189 2014 1234 1239
75. C.L. Lau, S.M. Palmer, K.E. Posther, and et al. Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients Ann Thorac Surg 69 2000 1520 1524
76. L.D. Snyder, A.L. Gray, J.M. Reynolds, and et al. Antibody desensitization therapy in highly sensitized lung transplant candidates Am J Transplant 14 2014 849 856
77. A.S. Shah, L. Nwakanma, C. Simpkins, and et al. Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients Ann Thorac Surg 85 2008 1919 1924
78. K.J. Tinckam, S. Keshavjee, C. Chaparro, and et al. Survival in sensitized lung transplant recipients with perioperative desensitization Am J Transplant 15 2015 417 426